+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Biotechnology Market, By Application (Bio-Pharmaceuticals, Bio-IT, Bio- Industrial, Bio-Agriculture), By End User (Biotechnology & Pharmaceutical Companies, Academic Institutions, Others), By Region, Competition Forecast & Opportunities, 2026

  • PDF Icon

    Report

  • 111 Pages
  • August 2021
  • Region: Global
  • TechSci Research
  • ID: 5410178
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Biotechnology Market stood at USD627.63 billion in 2020 and is expected to grow at a CAGR of 8.57% during the forecast period. The growth can be ascribed to the growing demand for biotechnology applications and products across various end-user industries including food, agriculture, healthcare, among others. Additionally, growing investments in the field of biotechnology as well as increasing demand for synthetic biology are further expected to spur the market growth over the next few years. Furthermore, the sudden outbreak and spread of the COVID-19 pandemic has increased the demand for biotechnology products such as vaccines, diagnostic tests, drugs, among others; thereby positively impacting the market growth. Besides, technological advancements and adoption & intersection of technologies such as Artificial Intelligence, Big Data Analytics, among others in the field of biotechnology is further expected to create lucrative opportunities for the growth over the next few years.





The Global Biotechnology Market can be segmented based on application, end-user, region and company. Based on application, the market can be categorized into bio-pharmaceuticals, bio-IT, bio-industrial and bio-agriculture. The bio-pharmaceuticals application segment is expected to dominate the market in 2020 with an overall market share of around 34.43%. This can be ascribed to the growing prevalence of different chronic and infectious diseases which require novel drugs for treatment. Furthermore, growing focus on the development of regenerative medicine coupled with increasing pharmaceutical expenditure across globe is further expected to support the segmental growth.



Regionally, North America dominated the market in 2020 and is expected to continue its dominance over the forecast period on account of high healthcare and R&D expenditure. Additionally, growing awareness and adoption pertaining to biotechnology and its applications and use in the region is further expected to boost the market growth. Also, the presence of major market players in the region is expected to further support the market growth. The companies operating in the region are launching advanced solutions to cater to the needs of the biotechnology industry.



Major companies operating in the Global Biotechnology Market include Novo Nordisk A/S, Regeneron Pharmaceuticals Inc., Amgen, Inc., CSL Limited, Gilead Sciences, Inc., Celgene Corporation, Allergan, Inc., Biogen Inc., Vertex Pharmaceuticals, Inc., F. Hoffmann-La Roche AG, Seagen Inc., Genmab A/S, Biocon Limited, Johnson & Johnson, Pfizer Inc., among others. The companies operating in the market are adopting various strategies like mergers & acquisitions, new product launches, new technology developments and investing in small start-up-companies in order to stay competitive in the market. For instance, in September 2020, F. Hoffmann-La Roche Ltd. completed the acquisition of Inflazome. Inflazome is an Irish biotechnology company which is involved in the development of inflammasome inhibitors. With this acquisition all the products of Inflazome will be added to the product portfolio of Roche. Also, in February 2021, Biogen Inc. received the U.S. FDA approval for PLEGRIDY (peginterferon beta-1a) that is used for the treatment of relapsing forms of multiple sclerosis. This approval will help the company expand its portfolio for multiple sclerosis treatments.



Years considered for this report:

  • Historical Years: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022-2026

Objective of the Study:

  • To analyze the historical growth in the market size of the Global Biotechnology Market from 2016 to 2020.
  • To estimate and forecast the market size of the Global Biotechnology Market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast the Global Biotechnology Market based on application, end-user, regional distribution, and company.
  • To identify dominant region or segment in the Global Biotechnology Market.
  • To identify drivers and challenges for the Global Biotechnology Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Biotechnology Market.
  • To identify and analyze the profile of leading players operating in the Global Biotechnology Market.
  • To identify key sustainable strategies adopted by market players in the Global Biotechnology Market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of service providers across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the service providers who could not be identified due to the limitations of secondary research. The publisher analyzed the service providers, distribution channels and presence of all major players across the globe.



The publisher calculated the market size of the Global Biotechnology Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.



Key Target Audience:

  • Biotechnology companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to biotechnology market

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, suppliers and partners, End-User, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.



Report Scope:


In this report, the Global Biotechnology Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:



Global Biotechnology Market, By Application:

  • Bio-Pharmaceuticals
  • Bio-IT
  • Bio- Industrial
  • Bio-Agriculture

Global Biotechnology Market, By End-User:

  • Biotechnology & Pharmaceutical Companies
  • Research Institutes & Laboratories
  • Academic Institutions
  • Others

Global Biotechnology Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Biotechnology Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.


Please note: With the Enterprise license, the PDF product is printable and editable and comes with a market data excel sheet.

Frequently Asked Questions about the Global Biotechnology Market

What is the estimated value of the Global Biotechnology Market?

The Global Biotechnology Market was estimated to be valued at $490.21 Billion in 2016.

What is the growth rate of the Global Biotechnology Market?

The growth rate of the Global Biotechnology Market is 7.9%, with an estimated value of $1046.21 Billion by 2026.

What is the forecasted size of the Global Biotechnology Market?

The Global Biotechnology Market is estimated to be worth $1046.21 Billion by 2026.

Who are the key companies in the Global Biotechnology Market?

Key companies in the Global Biotechnology Market include Novo Nordisk A/S, Regeneron Pharmaceuticals Inc., Amgen, Inc., CSL Limited, Gilead Sciences, Inc., Celgene Corporation, Allergan, Inc., Biogen Inc. and F. Hoffmann.

Table of Contents

1. Product Overview2. Research Methodology3. Impact of COVID-19 on Global Biotechnology Market4. Executive Summary
5. Global Biotechnology Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Application (Bio-Pharmaceuticals, Bio-IT, Bio- Industrial, Bio-Agriculture)
5.2.2. By End User (Biotechnology & Pharmaceutical Companies, Research Institutes & Laboratories, Academic Institutions, Others)
5.2.3. By Region
5.2.4. By Company (2020)
5.3. Product Market Map
6. North America Biotechnology Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Application
6.2.2. By End User
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Biotechnology Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Application
6.3.1.2.2. By End User
6.3.2. Canada Biotechnology Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Application
6.3.2.2.2. By End User
6.3.3. Mexico Biotechnology Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Application
6.3.3.2.2. By End User
7. Europe Biotechnology Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Application
7.2.2. By End User
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Biotechnology Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Application
7.3.1.2.2. By End User
7.3.2. France Biotechnology Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Application
7.3.2.2.2. By End User
7.3.3. United Kingdom Biotechnology Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Application
7.3.3.2.2. By End User
7.3.4. Italy Biotechnology Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Application
7.3.4.2.2. By End User
7.3.5. Spain Biotechnology Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Application
7.3.5.2.2. By End User
8. Asia-Pacific Biotechnology Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Application
8.2.2. By End User
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Biotechnology Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Application
8.3.1.2.2. By End User
8.3.2. Japan Biotechnology Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Application
8.3.2.2.2. By End User
8.3.3. India Biotechnology Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Application
8.3.3.2.2. By End User
8.3.4. South Korea Biotechnology Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Application
8.3.4.2.2. By End User
8.3.5. Australia Biotechnology Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Application
8.3.5.2.2. By End User
9. South America Biotechnology Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Application
9.2.2. By End User
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Biotechnology Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Application
9.3.1.2.2. By End User
9.3.2. Argentina Biotechnology Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Application
9.3.2.2.2. By End User
9.3.3. Colombia Biotechnology Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Application
9.3.3.2.2. By End User
10. Middle East and Africa Biotechnology Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Application
10.2.2. By End User
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Biotechnology Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Application
10.3.1.2.2. By End User
10.3.2. Saudi Arabia Biotechnology Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Application
10.3.2.2.2. By End User
10.3.3. UAE Biotechnology Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Application
10.3.3.2.2. By End User
10.3.4. Kuwait Biotechnology Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Application
10.3.4.2.2. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. Competitive Landscape
13.1. Novo Nordisk A/S
13.2. Regeneron Pharmaceuticals Inc.
13.3. Amgen, Inc.
13.4. CSL Limited
13.5. Gilead Sciences, Inc.
13.6. Celgene Corporation
13.7. Allergan, Inc.
13.8. Biogen Inc.
13.9. Vertex Pharmaceuticals, Inc.
13.10. F. Hoffmann-La Roche AG
13.11. Seagen Inc.
13.12. Genmab A/S
13.13. Biocon Limited
13.14. Johnson & Johnson
13.15. Pfizer Inc.
14. Strategic Recommendations15. About the Publisher & Disclaimer
List of Figures
Figure 1: Global Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 2: Global Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 3: Global Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 4: Global Biotechnology Market Share, By Region, By Value, 2016-2026F
Figure 5: Global Biotechnology Market Share, By Company, By Value, 2020
Figure 6: North America Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 7: North America Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 8: North America Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 9: North America Biotechnology Market Share, By Country, By Value, 2016-2026F
Figure 10: United States Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 11: United States Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 12: United States Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 13: Canada Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 14: Canada Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 15: Canada Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 16: Mexico Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 17: Mexico Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 18: Mexico Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 19: Europe Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 20: Europe Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 21: Europe Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 22: Europe Biotechnology Market Share, By Country, By Value, 2016-2026F
Figure 23: Germany Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 24: Germany Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 25: Germany Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 26: France Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 27: France Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 28: France Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 29: United Kingdom Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 30: United Kingdom Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 31: United Kingdom Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 32: Italy Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 33: Italy Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 34: Italy Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 35: Spain Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 36: Spain Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 37: Spain Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 38: Asia Pacific Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 39: Asia Pacific Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 40: Asia Pacific Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 41: Asia Pacific Biotechnology Market Share, By Country, By Value, 2016-2026F
Figure 42: China Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 43: China Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 44: China Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 45: Japan Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 46: Japan Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 47: Japan Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 48: India Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 49: India Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 50: India Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 51: South Korea Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 52: South Korea Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 53: South Korea Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 54: Australia Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 55: Australia Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 56: Australia Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 57: South America Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 58: South America Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 59: South America Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 60: South America Biotechnology Market Share, By Country, By Value, 2016-2026F
Figure 61: Brazil Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 62: Brazil Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 63: Brazil Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 64: Argentina Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 65: Argentina Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 66: Argentina Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 67: Colombia Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 68: Colombia Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 69: Colombia Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 70: Middle East & Africa Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 71: Middle East & Africa Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 72: Middle East & Africa Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 73: Middle East & Africa Biotechnology Market Share, By Country, By Value, 2016-2026F
Figure 74: South Africa Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 75: South Africa Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 76: South Africa Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 77: Saudi Arabia Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 78: Saudi Arabia Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 79: Saudi Arabia Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 80: UAE Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 81: UAE Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 82: UAE Biotechnology Market Share, By End User, By Value, 2016-2026F
Figure 83: Kuwait Biotechnology Market Size, By Value (USD Billion), 2016-2026F
Figure 84: Kuwait Biotechnology Market Share, By Application, By Value, 2016-2026F
Figure 85: Kuwait Biotechnology Market Share, By End User, By Value, 2016-2026F

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Novo Nordisk A/S
  • Regeneron Pharmaceuticals Inc.
  • Amgen, Inc.
  • CSL Limited
  • Gilead Sciences, Inc.
  • Celgene Corporation
  • Allergan, Inc.
  • Biogen Inc.
  • Vertex Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche AG
  • Seagen Inc.
  • Genmab A/S
  • Biocon Limited
  • Johnson & Johnson
  • Pfizer Inc.